funding, clinical trials

Expensive clinical trials and few drug approvals can drive up drug prices for consumers.

A year after the viral ALS awareness campaign raised millions, researchers say they have something to show for the influx of funds.

Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.

Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?

One of the leading scientific voices touting the health benefits of red wine fabricated data dozens of times.

Successful vaccines have been created to protect against pathogenic bacteria and viruses. Why aren’t there any for combating fungal infections?